|
Final Rule on Biologics Sterility Testing Contains Few Changes From Proposal
With just a few minor changes, the FDA has finalized a rule to provide greater flexibility for — and in some cases eliminate — sterility tests for biologics.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives